Recently, the San Francisco-based health plan reported positive results that showed a 56 percent reduction in overall opioid use among members with chronic, non-cancer pain from 2014 levels.
SiteOne Therapeutics, a San Francisco startup in the pain meds and pain diagnostics arena, has raised $1.5 million in an initial equity round. On top of that, it just secured a $1.4 million Phase II SBIR grant from the NIH. This early funding round was led by Sears Capital Management and Biobrit LLC. SiteOne’s technology, which […]
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.